The best health news search engine - My Health News » Medical News Today - Cancer/Oncology News » September 3, 2010 - Bird flu, Avian influenza, Diabetes, Cholesterol, Caner, HIV

Medical News Today - Cancer/Oncology News (19 unread)

Important Breakthrough In Origins Of Aggressive Breast Cancer

Posted: September 3rd, 2010, 10:00am CDT

Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell...
Need For Cancer Information And Support Expected To Double, UK

Posted: September 3rd, 2010, 9:00am CDT

Macmillan Cancer Support and Boots UK today officially launched a groundbreaking new three-year partnership, which aims to help provide the two million people living with cancer, and their family and friends, increased access to the information and support they need - when they need it, where they need it...
Celsion Receives SBIR Grant To Expand Its Technology Platform

Posted: September 3rd, 2010, 7:00am CDT

Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer"...
Cancer Drug Model Could Be A Potential Treatment For Alzheimer's - Alzheimer's Society Comment

Posted: September 3rd, 2010, 7:00am CDT

Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study. Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study published in the journal Nature...
Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium

Posted: September 3rd, 2010, 7:00am CDT

Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept...
Imec European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis

Posted: September 3rd, 2010, 5:00am CDT

Today, at the Engineering in Medicine and Biology Conference (EMBC) in Buenos Aires (Argentina), imec and its project partners have announced the launch of the European Seventh Framework Project MIRACLE. The MIRACLE project aims to develop an operational lab-on-chip for the isolation and detection of circulating and disseminated tumor cells (CTCs and DTCs) in blood...
Near Infrared Light May Open New Frontier In Fighting Cancer, Tay-Sachs

Posted: September 3rd, 2010, 5:00am CDT

A "game-changing" technique using near infrared light enables scientists to look deeper into the guts of cells, potentially opening up a new frontier in the fights against cancer and many other diseases. University of Central Florida chemists, led by Professor Kevin Belfield, used near infrared light and fluorescent dye to take pictures of cells and tumors deep within tissue...
Connection Between Light At Night (LAN) And Cancer Revealed

Posted: September 3rd, 2010, 4:00am CDT

A new study from the Center for Interdisciplinary Chronobiological Research at the University of Haifa has found an additional link between Light At Night (LAN) and cancer. This research joins a series of earlier studies carried out at the University of Haifa that also established the correlation...
Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain

Posted: September 3rd, 2010, 4:00am CDT

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls...
Asuragen's Clinical Laboratory Launches KRAS And BRAF Mutation Testing

Posted: September 3rd, 2010, 4:00am CDT

Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory...
Common Osteoporosis Drug Linked To Higher Risk Of Oesophageal Cancer

Posted: September 3rd, 2010, 4:00am CDT

A new UK study that followed a large number of people found that those who took 10 or more prescriptions for oral bisphosphonates, a group of drugs commonly used to treat the bone disease osteoporosis, were at higher risk of developing oesophageal cancer...
Molecular Imaging's Benefits In The Evaluation And Successful Treatment Planning For A Wide Spectrum Of Diseases

Posted: September 3rd, 2010, 3:00am CDT

A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma...
Chromosomal Rearrangement, Gene Copy Number Methods Featured In Cold Spring Harbor Protocols

Posted: September 3rd, 2010, 3:00am CDT

A cell devotes a significant amount of effort to maintaining the stability of its genome, preventing the sorts of chromosomal rearrangements characteristic of many cancers. Assays that measure the rate of gross chromosomal rearrangements (GCRs) are needed in order to understand the individual genes and the different pathways that suppress genomic instability...
Cancer Patients Pay The Price To Keep Warm , UK

Posted: September 3rd, 2010, 3:00am CDT

With temperatures set to plummet below freezing across the UK this week, leading cancer charity Macmillan Cancer Support is warning that keeping warm will be even harder for cancer patients undergoing treatment, as they are already twice as likely to fall into fuel poverty as the general population 1 ...
Macmillan's Response To NICE Decision On Liver Cancer Drug

Posted: September 3rd, 2010, 3:00am CDT

Responding to the decision by the National Institute for Health and Clinical Excellence (NICE) not to recommend sorafenib (Nexavar®) as a treatment for advanced liver cancer, Mike Hobday, Head of Campaigns at Macmillan Cancer Support, said: 'We are extremely disappointed that NICE has decided not to recommend sorafenib as a treatment for people with advanced liver cancer...
Novel Nanotechnology Collaboration Leads To Breakthrough In Cancer Research

Posted: September 3rd, 2010, 2:00am CDT

One of the most difficult aspects of working at the nanoscale is actually seeing the object being worked on. Biological structures like viruses, which are smaller than the wavelength of light, are invisible to standard optical microscopes and difficult to capture in their native form with other imaging techniques...
RNAi Screening Used For The First Time To Study Ewing's Sarcoma

Posted: September 3rd, 2010, 2:00am CDT

The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets, according to a scientific paper by the Translational Genomics Research Institute (TGen) published in the journal Molecular Cancer...
Immune System Finding May Lead To New Ways To Detect, Diagnose And Treat Cancer And Other Diseases

Posted: September 3rd, 2010, 2:00am CDT

When it comes to the mechanics of the human immune system, we are all more alike than previously thought, according to a new study by scientists at Fred Hutchinson Cancer Research Center. This finding has significant implications for developing new ways to detect, diagnose and treat cancer and diseases of the immune system, according to Harlan Robins, Ph.D...
News From The Journal Of Clinical Investigation: Sept. 1, 2010

Posted: September 3rd, 2010, 2:00am CDT

INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice...

← September 2 (15 items) September 4 (4 items) →

My Health News » Medical News Today - Cancer/Oncology News » September 3, 2010

Feeds

Medical News Today - Cancer/Oncology News (19 unread)

Posted: September 3rd, 2010, 10:00am CDT

Posted: September 3rd, 2010, 9:00am CDT

Posted: September 3rd, 2010, 7:00am CDT

Posted: September 3rd, 2010, 7:00am CDT

Posted: September 3rd, 2010, 7:00am CDT

Posted: September 3rd, 2010, 5:00am CDT

Posted: September 3rd, 2010, 5:00am CDT

Posted: September 3rd, 2010, 4:00am CDT

Posted: September 3rd, 2010, 4:00am CDT

Posted: September 3rd, 2010, 4:00am CDT

Posted: September 3rd, 2010, 4:00am CDT

Posted: September 3rd, 2010, 3:00am CDT

Posted: September 3rd, 2010, 3:00am CDT

Posted: September 3rd, 2010, 3:00am CDT

Posted: September 3rd, 2010, 3:00am CDT

Posted: September 3rd, 2010, 2:00am CDT

Posted: September 3rd, 2010, 2:00am CDT

Posted: September 3rd, 2010, 2:00am CDT

Posted: September 3rd, 2010, 2:00am CDT